4.3 Article

Regional difference and similarity of familial amyloidosis with polyneuropathy in France

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/13506129.2012.685665

关键词

French; FAP; TTR; late onset; phenotype; genotype

向作者/读者索取更多资源

Familial amyloidosis with polyneuropathy (FAP) in France have a large genetic heterogeneity with 29 transthyretin (TTR) gene mutations; Met30-TTR is the most frequent one (62%); followed by Tyr77-TTR (11.8%) and Phe77-TTR (6.2%). Analysis of 60 FAP patients diagnosed during the period 2008-2010 showed amyloid polyneuropathy was initially suspected in only 38% patients. TTR Met30 of Portuguese ancestry is different from TTR Met30 of non Portuguese ancestry and other non Met30 variants in geographical distribution and clinical presentation. There are three additional phenotypes of the neuropathy including multifocal upper limbs neuropathy, ataxic polyneuropathy and motor neuropathy. Patients with Tyr77-TTR are characterized by a late onset (>50 years), frequent ataxic phenotype; they are localized mainly in north of France. The more frequent use of the TTR genetic tests and the French network for FAP will help in the future to improve diagnosis and care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Medical Laboratory Technology

Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future

Suzan Boutary, Andoni Echaniz-Laguna, David Adams, Julien Loisel-Duwattez, Michael Schumacher, Charbel Massaad, Liliane Massaad-Massade

Summary: CMT1A, caused by a duplication on chromosome 17p11.2, is the most common form of CMT disease. Current treatments are symptomatic, but there is promising potential in PMP22-targeted small interfering RNA and antisense oligonucleotides.

TRANSLATIONAL RESEARCH (2021)

Article Clinical Neurology

Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease

Andreas Traschutz, Andrea Cortese, Selina Reich, Natalia Dominik, Jennifer Faber, Heike Jacobi, Annette M. Hartmann, Dan Rujescu, Solveig Montaut, Andoni Echaniz-Laguna, Sevda Erer, Valerie Cornelia Schutz, Alexander A. Tarnutzer, Marc Sturm, Tobias B. Haack, Nadege Vaucamps-Diedhiou, Helene Puccio, Ludger Schols, Thomas Klockgether, Bart P. van de Warrenburg, Martin Paucar, Dagmar Timmann, Ralf-Dieter Hilgers, Jose Gazulla, Michael Strupp, German Moris, Alessandro Filla, Henry Houlden, Mathieu Anheim, Jon Infante, A. Nazli Basak, Matthis Synofzik

Summary: The study found that RFC1 disease is common across different populations, with CANVAS and ACC as highly diagnostic features, but the phenotype is variable and overlapping, spanning a spectrum of multisystem diseases. Treatment trials require a large number of patients to detect reduced progression.

NEUROLOGY (2021)

Article Medical Laboratory Technology

Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory

Kenneth Chappell, Bruno Francou, Christophe Habib, Thomas Huby, Marco Leoni, Aurelien Cottin, Florian Nadal, Eric Adnet, Eric Paoli, Christophe Oliveira, Celine Verstuyft, Anne Davit-Spraul, Pauline Gaignard, Elise Lebigot, Jean-Charles Duclos-Vallee, Jacques Young, Peter Kamenicky, David Adams, Andoni Echaniz-Laguna, Emmanuel Gonzales, Claire Bouvattier, Agnes Linglart, Veronique Picard, Emilie Bergoin, Emmanuel Jacquemin, Anne Guiochon-Mantel, Alexis Proust, Jerome Bouligand

Summary: This study reports 5 years of experience in using the Galaxy platform for high-throughput sequencing data analysis in a clinical laboratory setting. The results demonstrate that Galaxy is a suitable platform with great potential to benefit patient care in a clinical laboratory setting.

CLINICAL CHEMISTRY (2022)

Article Clinical Neurology

Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis

Luca Leonardi, Clovis Adam, Guillemette Beaudonnet, Diane Beauvais, Cecile Cauquil, Adeline Not, Olivier Morassi, Anouar Benmalek, Olivier Trassard, Andoni Echaniz-Laguna, David Adams, Celine Labeyrie

Summary: This study aimed to assess the role of skin biopsy as a marker of disease onset and severity in hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN). The results showed that skin amyloid deposits are a marker of ATTRv-PN disease onset, and decreased intraepidermal nerve fiber density (IENFD) is a marker of disease progression.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Nitrous oxide-induced predominantly motor neuropathies: a follow-up study

Edouard Berling, Guillaume Fargeot, Karine Aure, Tuan Huy Tran, Nathalie Kubis, Pierre Lozeron, Adrien Zanin

Summary: Recreational nitrous oxide abuse can lead to severe motor neuropathy and ataxia in young patients, with elevated homocysteine levels and normal cobalamin levels. Despite vitamin B12 supplementation, symptoms may only partially resolve, highlighting the need for long-term follow-up to assess the severity of these toxic neuropathies.

JOURNAL OF NEUROLOGY (2022)

Article Genetics & Heredity

Convergence of patient-and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

Benoit Sanson, Caroline Stalens, Celine Guien, Luisa Villa, Catherine Eng, Sitraka Rabarimeriarijaona, Rafaelle Bernard, Pascal Cintas, Guilhem Sole, Vincent Tiffreau, Andoni Echaniz-Laguna, Armelle Magot, Raul Juntas Morales, Francois Constant Boyer, Aleksandra Nadaj-Pakleza, Agnes Jacquin-Piques, Christophe Beroud, Sabrina Sacconi, French Fshd Registry Collaboration Group

Summary: The study evaluated the data quality of the French National Registry of FSHD. The results showed that patient and physician answers were largely concordant when addressing quantitative and objective items. However, there was a poor correlation between data provided in the two forms for FSHD-specific signs. The revised data collection forms rely more on patient-reported data to improve efficiency and quality of data collection.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Clinical Neurology

Anti-disialosyl-immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study

Claire Peillet, David Adams, Shahram Attarian, Francoise Bouhour, Cecile Cauquil, Julien Cassereau, Jean-Baptiste Chanson, Pascal Cintas, Alain Creange, Emilien Delmont, Guillaume Fargeot, Steeve Genestet, Antoine Gueguen, Anne Laure Kaminsky, Thierry Kuntzer, Celine Labeyrie, Maud Michaud, Yann Pereon, Angela Puma, Karine Viala, Pascale Chretien, Clovis Adam, Andoni Echaniz-Laguna

Summary: Chronic neuropathies with anti-disialosyl ganglioside IgM antibodies have distinctive clinical features, with most patients responsive to intravenous immunoglobulins and showing a favorable prognosis in the majority of cases.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Cardiac & Cardiovascular Systems

Cardiac Outcomes in Adults With Mitochondrial Diseases

Konstantinos Savvatis, Christoffer Rasmus Vissing, Lori Klouvi, Anca Florian, Mehjabin Rahman, Anthony Behin, Abdallah Fayssoil, Marion Masingue, Tanya Stojkovic, Henri Marc Becane, Nawal Berber, Fanny Mochel, Denis Duboc, Bertrand Fontaine, Bjorg Krett, Caroline Stalens, Julie Lejeune, Robert D. S. Pitceathly, Luis Lopes, Malika Saadi, Thomas Gossios, Vincent Procaccio, Marco Spinazzi, Celine Tard, Pascal De Groote, Claire-Marie Dhaenens, Claire Douillard, Andoni Echaniz-Laguna, Ros Quinlivan, Michael G. Hanna, Ali Yilmaz, John Vissing, Pascal Laforet, Perry Elliott, Karim Wahbi

Summary: This study aimed to develop prediction models for heart failure and arrhythmic MACE in patients with mitochondrial diseases. The results showed that specific genetic variants and cardiac assessments could serve as predictors. These models demonstrated high predictive accuracy.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Article Clinical Neurology

Treating hereditary transthyretin amyloidosis: Present & future challenges

A. Echaniz-Laguna, C. Cauquil, C. Labeyrie, D. Adams

Summary: Hereditary transthyretin amyloidosis (ATTRv) is a rare, lethal, autosomal dominant disorder caused by mutations in the TTR gene. Recent therapeutic breakthroughs include effective treatments using small interfering RNA (siRNA) and antisense oligonucleotide (ASO) targeting liver TTR mRNA, as well as CRISPR-Cas9-based TTR gene editing. These developments have shifted the paradigm of treating ATTRv and offer potential treatments for other genetic disorders.

REVUE NEUROLOGIQUE (2023)

Article Biochemistry & Molecular Biology

Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Pierre Socie, Anouar Benmalek, Cecile Cauquil, Eve Piekarski, Ilias Kounis, Ludivine Eliahou, Antoine Rousseau, Francois Rouzet, Andoni Echaniz-Laguna, Didier Samuel, David Adams, Michel S. Slama, Vincent Algalarrondo

Summary: By stabilizing transthyretin, tafamidis delays progression of amyloidosis due to transthyretin variant (ATTRv) and replaced liver transplantation (LT) as the first-line therapy. This study compared the effects of these two treatment strategies and found that patients treated with tafamidis had longer survival but higher risks of cardiac and neurological deterioration compared to liver transplantation.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2023)

Article Clinical Neurology

Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease

Luce Barbat du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, Aleksandra Nadaj-Pakleza, Jean-Baptiste Chanson, Simon Frachet, Laurent Magy, Julien Cassereau, Pascal Cintas, Ariane Choumert, Perrine Devic, Sarah Leonard Louis, Robinson Gravier Dumonceau, Emilien Delmont, Emmanuelle Salort-Campana, Francoise Bouhour, Philippe Latour, Tanya Stojkovic, Shahram Attarian

Summary: This study investigated the clinical presentation of patients with CMTX1 and found that women usually have milder clinical symptoms compared to men. The study also identified two subgroups of women over the age of 48, with one group showing similar disease progression to men.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

EGR2 gene-linked hereditary neuropathies present with a bimodal age distribution at symptoms onset

Andoni Echaniz-Laguna, Cecile Cauquil, Jean-Baptiste Chanson, Celine Tard, Lucie Guyant-Marechal, Thierry Kuntzer, Ioana Maria Ion, Anne-Sophie Lia, Jerome Bouligand, Vianney Poinsignon

Summary: Mutations in the EGR2 gene cause various hereditary neuropathies, including CMT1D, CHN1, DSS, and CMT2. Our study found that EGR2 gene-related neuropathies are rare, slowly progressive demyelinating neuropathies with two major clinical presentations: childhood-onset and adult-onset variants.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2023)

Article Medicine, General & Internal

Red Flags for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Sarcoidosis or Connective Tissue Diseases

Clement Vialatte de Pemille, Nicolas Noel, Clovis Adam, Celine Labeyrie, Adeline Not, Guillemette Beaudonnet, Andoni Echaniz-Laguna, David Adams, Cecile Cauquil

Summary: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disorder of the peripheral nervous system that requires distinguishing from sarcoidosis-associated CIDP (SAR-CIDP) and connective tissue disease-associated CIDP (CTD-CIDP). In this study, SAR-CIDP was found to have an acute or subacute onset, while CTD-CIDP was mostly associated with Sjogren's syndrome and lupus and had a chronic onset. Age at onset, presentation, onset of symptoms, and weight loss were identified as important factors for differentiating SAR-CIDP and CTD-CIDP. Response to intravenous immunoglobulin therapy was lower in the combined SAR-CIDP and CTD-CIDP group.

JOURNAL OF CLINICAL MEDICINE (2023)

Meeting Abstract Clinical Neurology

SKIN AMYLOID DEPOSITS AND NERVE FIBER LOSS AS MARKERS OF NEUROPATHY ONSET AND PROGRESSION IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS

Luca Leonardi, Clovis Adam, Beaudonnet Guillemette, Beauvais Diane, Cauquil Cecile, Adeline Not, Olivier Morassi, Benmalek Anouar, Olivier Trassard, Andoni Echaniz-Laguna, David Adams, Celine Labeyrie

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2022)

Meeting Abstract Clinical Neurology

SKIN AMYLOID DEPOSITS AND NERVE FIBER LOSS AS MARKERS OF NEUROPATHY ONSET AND PROGRESSION IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: DATA FROM A LARGE FRENCH COHORT

Luca Leonardi, David Adams, Clovis Adam, Guillemet Beaudonnet, Diane Beauvais, Cecile Cauquil, Adeline Not, Olivier Morassi, Andoni Echaniz-Laguna, Celine Labeyrie

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2022)

暂无数据